NNF Center for Basic Metabolic Research and Department of Biomedical Sciences, Panum Institute, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
NNF Center for Basic Metabolic Research and Department of Biomedical Sciences, Panum Institute, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1123-30. doi: 10.1152/ajpendo.00012.2015. Epub 2015 Apr 21.
Neurotensin (NT) is a neurohormone produced in the central nervous system and in the gut epithelium by the enteroendocrine N cell. NT may play a role in appetite regulation and may have potential in obesity treatment. Glucose ingestion stimulates NT secretion in healthy young humans, but the mechanisms involved are not well understood. Here, we show that rats express NT in the gut and that glucose gavage stimulates secretion similarly to oral glucose in humans. Therefore, we conducted experiments on isolated perfused rat small intestine with a view to characterize the cellular pathways of secretion. Luminal glucose (20% wt/vol) stimulated secretion but vascular glucose (5, 10, or 15 mmol/l) was without effect. The underlying mechanisms depend on membrane depolarization and calcium influx, since the voltage-gated calcium channel inhibitor nifedipine and the KATP channel opener diazoxide, which causes hyperpolarization, eliminated the response. Luminal inhibition of the sodium-glucose cotransporter 1 (SGLT1) (by phloridzin) eliminated glucose-stimulated release as well as secretion stimulated by luminal methyl-α-D-glucopyranoside (20% wt/vol), a metabolically inactive SGLT1 substrate, suggesting that glucose stimulates secretion by initial uptake by this transporter. However, secretion was also sensitive to GLUT2 inhibition (by phloretin) and blockage of oxidative phosphorylation (2-4-dinitrophenol). Direct KATP channel closure by sulfonylureas stimulated secretion. Therefore, glucose stimulates NT secretion by uptake through SGLT1 and GLUT2, both causing depolarization either as a consequence of sodium-coupled uptake (SGLT1) or by closure of KATP channels (GLUT2 and SGLT1) secondary to the ATP-generating metabolism of glucose.
神经降压素(NT)是一种神经激素,由肠内分泌 N 细胞在中枢神经系统和肠上皮中产生。NT 可能在食欲调节中发挥作用,并可能在肥胖治疗中有潜力。葡萄糖摄入刺激健康年轻人类的 NT 分泌,但涉及的机制尚不清楚。在这里,我们表明大鼠在肠道中表达 NT,并且葡萄糖灌胃刺激分泌类似于人类口服葡萄糖。因此,我们在分离灌注的大鼠小肠上进行了实验,以期表征分泌的细胞途径。腔葡萄糖(20%wt/vol)刺激分泌,但血管葡萄糖(5、10 或 15mmol/l)没有作用。潜在的机制取决于膜去极化和钙内流,因为电压门控钙通道抑制剂硝苯地平(nifedipine)和 KATP 通道开放剂二氮嗪(diazoxide)消除了反应,二氮嗪导致超极化。腔抑制钠-葡萄糖共转运蛋白 1(SGLT1)(用 phloridzin)消除了葡萄糖刺激的释放以及腔甲基-α-D-吡喃葡萄糖苷(20%wt/vol)刺激的释放,这是一种代谢上无活性的 SGLT1 底物,表明葡萄糖通过该转运体的初始摄取刺激分泌。然而,分泌对 GLUT2 抑制(用 phloretin)和氧化磷酸化阻断(2-4-二硝基苯酚)也很敏感。磺酰脲类药物直接关闭 KATP 通道刺激分泌。因此,葡萄糖通过 SGLT1 和 GLUT2 摄取刺激 NT 分泌,这两种转运蛋白都通过钠偶联摄取(SGLT1)引起去极化,或者通过葡萄糖代谢产生的 ATP 生成导致 KATP 通道关闭(GLUT2 和 SGLT1)引起去极化。